The countries who have tended to focus on their protectionism – US, England, several European countries, definitely not China – seem to be the ones where there is a fear, real or induced by politicians, that the working class is losing out because of globalization. This fear is either due to “foreigners” that are taking…
This article was originally posted by CNBC.com Kari Firestone’s newest article discusses why the incentives for companies and research organizations may not be aligned with customers’ desire for lower drug prices. Additionally, the legal complexity of the Medicare system leaves the government with no negotiating power, further inflating prescription drug prices. Read the full article…
It’s time for courts to weigh in on the issue of drug pricing. As an investor, we want drug companies to earn a strong return on their investment – but using the “value of a life” thesis to justify price is too arbitrary as that might be infinite. Read the full article in The New…
My newest piece focuses on political diversity in the workplace. In a country more polarized than perhaps at any other time in history, it’s still important to avoid political homogeneity in the workplace. In addition, I offers some principles I’ve used as a boss for smoothly navigating political discussions. Read the full story in The Harvard…
While it’s easy to see both the points of view of the Black cabbies and the often-immigrant Uber drivers in London, the key is designing a solution so both sides feel equally vindicated and compromised. Read the full story in The New York Times
Kari wrote an op-ed for CNBC today. In it she describes a useful set of principles that anyone can utilize in this new age of market unpredictability and bizarre presidential Tweets. Read the full article on CNBC.com
The cost of convenience and lower pricing to shop will be an incredible loss of jobs and potential obliteration of local communities and towns. We haven’t figured out how to replace that loss. Read the full story in The New York Times